HUM vs SERA
Humana Inc (HUM) versus Sera Prognostics Inc (SERA) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Sera Prognostics Inc (SERA) is a medical devices company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported SERA revenue for 2024-12-31 was $77.0K. Net income was -$32.9M. Revenue was down 74.8% from 2023-12-31 to 2024-12-31. SERA currently screens at market cap $89.1M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. SERA currently screens at market cap $89.1M.
Not investment advice. Open the HUM and SERA stock pages for the full models.
Not investment advice.